Company / Shareholders' Equity
Elanco Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$6.5B
FY2025
5-year range
$6.1B / $7.5B
FY2021-FY2025
Trend
+7.4%
vs FY2024
Sector context
#17 of 213
Health Care
What the data says
Among 213 Health Care companies, Elanco is in the top 8% for shareholders' equity. Shareholders' Equity returned to growth in FY2025 after 4 years of decline, reaching $6.5B.
Based on SEC 10-K filings.
$6.5B in FY2025 with a 5-year CAGR of -5.0%. Top quartile in the Health Care sector.
Improved from $6.2B to $6.5B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -3.5%
- 5-Year CAGR
- -5.0%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 213This company $6.5B Sector average $2.5B
▼
+156.9% above sector average
Key checks
Key Insights
- 5-year CAGR of -5.0%, indicating a declining trend.
- In FY2025, shareholders' equity increased 7.4% year-over-year.
- Ranks #17 out of 213 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.5B | +7.4% |
| FY2024 | $6.1B | -2.0% |
| FY2023 | $6.2B | -14.6% |
| FY2022 | $7.3B | -2.9% |
| FY2021 | $7.5B | -11.2% |
| FY2020 | $8.5B | +52.6% |
| FY2019 | $5.5B | +6.7% |
| FY2018 | $5.2B | -33.2% |
| FY2017 | $7.8B | +10.9% |
| FY2016 | $7.0B | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026